Immature B cells in bone marrow express Fas/FasL

Scandinavian Journal of Immunology

Volumn 51, Issue 3, 2000, Pages 279-284

  Nilsson, N ^a   Ingvarsson, S ^a   Borrebaeck, C A K ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; FAS ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOPOIESIS; PRIORITY JOURNAL;

ANTIGENS, CD19; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTE SUBSETS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; FAS LIGAND PROTEIN; HUMANS; LEUKEMIA, PRE-B-CELL; LIGANDS; MEMBRANE GLYCOPROTEINS; RECEPTORS, ANTIGEN, B-CELL; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0034114093     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00701.x     Document Type: Article

References (27)

1. Itoh N, Tsujimoto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
2. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH, Möller P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69:415-29.
3. Nishimura Y, Ishii A, Kobayashi Y, Yamasaki Y, Yonehara S. Expression and function of mouse Fas antigen on immature and mature T cells. J Immunol 1995;154:4395-403.
4. Yoshino T, Kondo E, Cao L, Takahashi K, Hayashi K, Nomura S, Akagi T. Inverse expression of bc1-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 1994;83:1856-61.
5. Cohen PL, Eisenberg RA. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991;9:243-69.
6. Debatin K-M, Süss D, Krammer PH. Differential expression of APO-1 on human thymocytes: Implications for negative selection. Eur J Immunol 1994;24:753-8.
7. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
8. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S. Fas ligand in human serum. Nature Med 1996;2:317-22.
9. Hahne M, Renno T, Schroeter M, Irmler M, French L, Bomand T, MacDonald HR, Tschopp J. Activated B cells express functional Fas ligand. Eur J Immunol 1996;26:721-4.
10. Van Parijs L, Abbas AK. Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol 1996;8:355-61.
11. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-92.
12. Hahne M, Rimoldi D, Schröter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J-C, Tschopp J. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape. Science 1996;274:1363-6.
13. Saas P, Walker PR, Hahne M, Quiquerez A-L, Schnuriger V, Perrin G, French L, Van Meir EG, De Tribolet N, Tschopp J, Dietrich P-Y. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilige in the brain? J Clin Invest 1997;99:1173-8.
14. Osmond DG. The turnover of B-cell population. Immunol Today 1993;14:34-7.
15. Melchers F, Rolink A, Grawunder U, Winkler TH, Karasuyama H, Ghia P, Andersson J. Positive and negative selection events during B lymphopoiesis. Curr Opin Immunol 1995;7:214-27.
16. Osmond DG, Rico-Vargas S, Valenzona H, Fauteux L, Liu L, Janani R, Lu L, Jacobsen K. Apoptosis and macrophage-mediated cell deletion in the regulation of B lymphopoiesis in mouse bone marrow. Immunol Rev 1994;142:209-30.
17. Krammer PH, Dhein J, Walczak H, Bermann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendrop MO, Stricker K, Bäumler C, Hellbardt S, Germer M, Peter ME, Debatin K-M. The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 1994;142:175-91.
18. Dhein J, Walczak H, Baümler C, Debatin K-M, Krammer PH. Auto-crine T-cell suicide mediated by APO-1/. Nature 1995;373:438-41.
19. Brunner T, Mogil R, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-4.
20. + T cells. Nature 1995;376:181-4.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
22. Vernino L, McAnally LM, Ramberg J, Lipsky PE. Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells. J Immunol 1992;148:404-10.
23. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis family. Cell 1993;75:1169-78.
24. Scott DW, Grdina T, Shi Y. T cells commit suicide, but B cells are murdered. J Immunol 1996;156:2352-6.
25. Nishiuchi R, Yoshino T, Matsuo Y, Sakuma I, Cao L, Seino Y, Takahashi K, Akagi T. The Fas antigen is detected on immature B cells and the representative cell lines show Fas-mediated apoptosis. Br J Haematol 1996;92:302-7.
26. Rothstein TL, Lang JKM, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju S-T, Marshak-Rothstein A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995;374:163-5.
27. Norvell A, Mandik L, Monroe JG. Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J Immunol 1995;154:4404-13.